Pfizer and BioNTech to Supply U.S. with 100 Million Additional COVID-19 Vaccine Doses

Pfizer and BioNTech to Supply U.S. with 100 Million Additional COVID-19 Vaccine Doses

Pfizer and BioNTech agreed on Wednesday with the U.S. government to supply additional 100 million doses of COVID-19 vaccine, according to the company’s press release. The agreement brings the total number of doses to be delivered to the U.S. to 200 million.

  • Pfizer and BioNTech expect to deliver the full 200 million doses to Operation Warp Speed (OWS) by July 31, 2021
  • U.S. government will pay $1.95 billion for the additional 100 million doses based on the initial agreement
  • The U.S. government also has the option to acquire up to an additional 400 million doses of the Pfizer-BioNTech vaccine.

Pfizer stock is currently gaining as BioNTech loses. PFE: NYSE is up 1.50%, BNTX: NASDAQ is down 5.44%

Our Experts


Daniel Michelson

Daniel is a long term investor and position trader in the forex market.

Reva Green

Reva Green is the Senior Editor for website. An experienced media professional, Reva has close to a decade of editorial experience with a background.

Shandor Brenner

Shandor Brenner, an experienced writer at fxaudit.com, brings a wealth of knowledge with over 20 years in the investment field.

Leave a Reply

CAPTCHA ImageChange Image